126
Participants
Start Date
June 19, 2015
Primary Completion Date
February 25, 2019
Study Completion Date
May 7, 2020
BMS-986148
Nivolumab
Local Institution - 0009, Brussels
Local Institution - 0013, Liverpool
Local Institution - 0004, Clayton
Local Institution - 0014, Adelaide
Local Institution - 0015, Nedlands
Local Institution - 0008, Ghent
Local Institution - 0016, Rozzano (milano)
Local Institution - 0018, Milan
Local Institution - 0017, Milan
Duke University Medical Center, Durham
Moores Cancer Center, La Jolla
Local Institution - 0002, Edmonton
Local Institution - 0003, Toronto
Local Institution - 0010, Amsterdam
Local Institution - 0011, Rotterdam
Local Institution - 0007, Southampton
Local Institution - 0006, Glasgow
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY